Loan Agreements in the Pharmaceuticals Industry

742 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (4 contracts)
Acacia Diversified Holdings, Inc. (2)
ACELRX PHARMACEUTICALS INC (9)
Acer Therapeutics Inc. (3)
ACHILLION PHARMACEUTICALS INC (1)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (6)
ACURA PHARMACEUTICALS, INC (11)
Adamis Pharmaceuticals Corp (13)
Aegerion Pharmaceuticals, Inc. (12)
AERIE PHARMACEUTICALS INC (2)
AGILE THERAPEUTICS INC (4)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (8)
Alexza Pharmaceuticals Inc. (1)
ALIMERA SCIENCES INC (20)
Allergan, plc (1)
Altus Pharmaceuticals Inc. (1)
AmeriCann, Inc. (16)
Amneal Pharmaceuticals, Inc. (4)
Amphastar Pharma (10)
Ampio Pharmaceuticals, Inc. (1)
AMYLIN PHARMACEUTICALS INC (1)
Anacor Pharmaceuticals, Inc. (3)
Anebulo Pharmaceuticals, Inc. (1)
ANI Pharma Inc (2)
Anthera Pharmaceuticals Inc (2)
APRICUS BIOSCIENCES, INC. (2)
ARIAD PHARMACEUTICALS INC (1)
Arog Pharmaceuticals, Inc. (3)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
ATAI Life Sciences B.V. (2)
Auspex Pharmaceuticals, Inc. (4)
AUXILIUM PHARMACEUTICALS INC (4)
Axsome Therapeutics, Inc. (8)
AYTU BIOSCIENCE, INC (4)
BENTLEY PHARMACEUTICALS INC (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (7)
Biofrontera Inc. (4)
BioPharmX Corp (3)
Biostar Pharmaceuticals, Inc. (1)
BODY & MIND INC. (12)
Bristol-Myers Squibb (2)
CADENCE PHARMACEUTICALS INC (4)
Canbiola, Inc. (1)
Cannabics Pharmaceuticals Inc. (1)
Cantabio Pharmaceuticals Inc. (7)
Celator Pharmaceuticals Inc (2)
Cerecor Inc. (10)
CHINA PHARMA HOLDINGS, INC. (3)
China Pharmaceuticals Inc (2)
Clearside Biomedical, Inc. (9)
CLS Holdings USA, Inc. (4)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (14)
ContraVir Pharmaceuticals, Inc. (1)
COSMO VENTURES INC (1)
CUBIST PHARMACEUTICALS INC (1)
CUMBERLAND PHARMACEUTICALS INC (22)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (1)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (8)
Egalet Corp (4)
Elanco Animal Health Inc (8)
ELITE PHARMACEUTICALS INC (6)
Elixir Pharmaceuticals, Inc. (2)
Eloxx Pharmaceuticals, Inc. (5)
Endo International plc (1)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (1)
Evoke Pharma Inc (6)
Evolus, Inc. (6)
Exactus, Inc. (2)
EYENOVIA, INC. (5)
EyePoint Pharmaceuticals, Inc. (6)
Fresenius Kabi Pharmaceuticals Holding, Inc. (3)
FRONTIER OILFIELD SERVICES INC (1)
Furiex Pharmaceuticals, Inc. (1)
GB SCIENCES INC (2)
GENAISSANCE PHARMACEUTICALS INC (1)
GREEN HYGIENICS HOLDINGS INC. (2)
HARROW HEALTH, INC. (10)
Horizon Pharma plc (8)
IMAGING3 INC (2)
Innovive Pharmaceuticals, Inc. (1)
INSPIRE PHARMACEUTICALS INC (2)
IntelGenx Technologies Corp. (5)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (12)
Item 9 Labs Corp. (3)
Iterum Therapeutics plc (4)
Jaguar Health, Inc. (3)
JAVELIN PHARMACEUTICALS, INC (3)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (1)
Jushi Holdings Inc. (3)
Kala Pharmaceuticals, Inc. (7)
Kaleido Biosciences, Inc. (2)
KEMPHARM, INC (4)
KID CASTLE EDUCATIONAL CORP (6)
KOS PHARMACEUTICALS INC (1)
Lannett Company, Inc. (2)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (2)
Lipocine Inc. (2)
Liquidia Corp (3)
Liquidia Technologies Inc (2)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
Mallinckrodt (2)
MAP Pharmaceuticals, Inc. (5)
MARINUS PHARMACEUTICALS INC (5)
Medicine Man Technologies, Inc. (2)
Melt Pharmaceuticals, Inc. (3)
MEMORY PHARMACEUTICALS CORP (3)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (2)
MJ Holdings, Inc. (2)
Mylan N.V. (1)
MYnd Analytics, Inc. (4)
Nabriva Therapeutics plc (5)
NEKTAR THERAPEUTICS (1)
Neos Therapeutics, Inc. (3)
Notis Global, Inc. (1)
Novan, Inc. (3)
OMEROS CORP (20)
Omthera Pharmaceuticals, Inc. (1)
ORAMED PHARMACEUTICALS INC. (1)
OTONOMY, INC. (3)
Pacira Pharmaceuticals, Inc. (3)
PANACOS PHARMACEUTICALS, INC. (2)
Paratek Pharmaceuticals, Inc. (10)
Perrigo (4)
PetLife Pharmaceuticals, Inc. (2)
Petros Pharmaceuticals, Inc. (4)
Phathom Pharmaceuticals, Inc. (9)
Phibro Animal Health Corporation (7)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (1)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (2)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (2)
QUATRX PHARMACEUTICALS CO (2)
RADIENT PHARMACEUTICALS Corp (1)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (4)
Reliant Pharmaceuticals, Inc. (1)
resTORbio, Inc. (8)
Revance Therapeutics, Inc. (4)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (3)
Sagent Pharmaceuticals, Inc. (5)
SALIX PHARMACEUTICALS LTD (1)
Satsuma Pharmaceuticals, Inc. (1)
SCICLONE PHARMACEUTICALS INC (3)
scPharmaceuticals Inc. (4)
SCYNEXIS INC (4)
Sienna Biopharmaceuticals, Inc. (2)
SIGA TECHNOLOGIES INC (4)
Sonoma Pharmaceuticals, Inc. (2)
Strongbridge Biopharma plc (2)
Sucampo Pharmaceuticals, Inc. (1)
SUNWIN STEVIA INTERNATIONAL, INC. (3)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (3)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (2)
TAURIGA SCIENCES, INC. (1)
Telomir Pharmaceuticals, Inc. (1)
Terra Tech Corp. (7)
TETRAPHASE PHARMACEUTICALS INC (4)
TEVA PHARMACEUTICAL INDUSTRIES LTD (6)
Textmunication Holdings, Inc. (2)
Tilray, Inc. (1)
TILT Holdings Inc. (1)
TITAN PHARMACEUTICALS INC (8)
Tongli Pharmaceuticals (USA), Inc. (4)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Tricida, Inc. (8)
Trubion Pharmaceuticals, Inc (1)
Trulieve Cannabis Corp. (1)
Upjohn Inc (2)
Urovant Sciences Ltd. (3)
Verano Holdings Corp. (1)
Verona Pharma plc (5)
Verrica Pharmaceuticals Inc. (6)
VIA Pharmaceuticals, Inc. (4)
Vitae Pharmaceuticals, Inc (2)
VIVUS INC (1)
Vyrix Pharmaceuticals, Inc. (2)
XERIS PHARMACEUTICALS INC (9)
Zoetis (1)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

Loan Agreement by and among the Company, the Companys wholly-owned subsidiaries, ALT Debt II, LP and GGG Partners, LLC, as collateral agent (4Front Ventures Corp., Filed With SEC on April 15, 2024)
Amended and Restated Loan and Security Agreement dated December 17, 2020 (4Front Ventures Corp., Filed With SEC on April 15, 2024)
Business Loan and Security Agreement dated March 26, 2024 (FRONTIER OILFIELD SERVICES INC, Filed With SEC on April 15, 2024)
First Amendment to the Bridge Loan Agreement by and between the Registrant and Acer Therapeutics Inc (KEMPHARM, INC, Filed With SEC on April 1, 2024)
Loan Settlement Agreement between China Pharma Holdings, Inc. and Ms. Zhilin Li (CHINA PHARMA HOLDINGS, INC., Filed With SEC on April 1, 2024)
Third Amended and Restated Loan Agreement by and among IntelGenx Technologies Corp., IntelGenx Corp. and ATAI Life Sciences AG, dated March 11, 2024 (IntelGenx Technologies Corp., Filed With SEC on March 25, 2024)
Business Loan and Security Agreement between Biofrontera Inc. and Cedar Advance, LLC, dated as of December 21, 2023 (Biofrontera Inc., Filed With SEC on March 15, 2024)
Amended and Restated Business Loan and Security Agreement between Biofrontera Inc. and Agile Capital Funding, LLC and Agile Lending, LLC, dated as of December 21, 2023 (Biofrontera Inc., Filed With SEC on March 15, 2024)
Fourth Amendment to the Loan and Security Agreement, dated December 14, 2023, by and among Hercules Capital and the Registrant (Phathom Pharmaceuticals, Inc., Filed With SEC on March 7, 2024)
Loan Agreement dated December 22, 2023 between Trulieve Centaury Way, LLC and First Federal Bank (Trulieve Cannabis Corp., Filed With SEC on February 29, 2024)
First Amendment and Consent to Amended and Restated Loan Agreement, dated as of January 3, 2023, by and among Collegium Pharmaceutical, Inc., the guarantors party thereto,... (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on February 22, 2024)
Second Amendment to Amended and Restated Loan and Security Agreement dated January 29, 2024 (4Front Ventures Corp., Filed With SEC on February 1, 2024)
Loan Agreement, dated as of December 26, 2023, by and between Borrower and First Federal Bank (Verano Holdings Corp., Filed With SEC on January 2, 2024)
Loan and Security Agreement, dated as of December 27, 2023, by and among Verona Pharma, Inc., Oxford Finance LLC, as collateral agent and as a lender, and the other lenders party... (Verona Pharma plc, Filed With SEC on January 2, 2024)
Promissory Note and Loan Agreement, dated June 15, 2023, by and between Telomir Pharmaceuticals, Inc. and Bay Shore Trust (Telomir Pharmaceuticals, Inc., Filed With SEC on December 14, 2023)
Loan Modification Agreement (AmeriCann, Inc., Filed With SEC on December 11, 2023)
Promissory Note and Loan Agreement, by and between the Company and MIRALOGX, dated as of November 15, 2023 (MIRA PHARMACEUTICALS, INC., Filed With SEC on November 20, 2023)
Loan and Security Agreement dated November 13, 2023, among the Company, 22NW LP as administrative agent, collateral agent and as a lender, and JFL Capital Management LLC (Anebulo Pharmaceuticals, Inc., Filed With SEC on November 14, 2023)
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Eloxx Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Eloxx Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
Second Amendment to Loan and Security Agreement, dated as of August 28, 2023, by and among Registrant, Hercules Capital, Inc. and First-Citizens Bank & Trust Company (Tarsus Pharmaceuticals, Inc., Filed With SEC on November 9, 2023)
First Amendment to the Bridge Loan Agreement dated as of October 31, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (Acer Therapeutics Inc., Filed With SEC on November 2, 2023)
First Amendment to Secured Bridge Loan Agreement, dated October 27, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US... (BioPharmX Corp, Filed With SEC on October 30, 2023)
Second Amended and Restated Loan Agreement between IntelGenx Technologies Corp. and ATAI Life Sciences AG, dated September 30, 2023 (IntelGenx Technologies Corp., Filed With SEC on October 12, 2023)
First Amendment to Loan Agreement, dated as of September 13, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I,... (Cerecor Inc., Filed With SEC on September 13, 2023)
Loan Termination Agreement dated September 1, 2023, by and between CGSF Group LLC and SFNY Holdings, Inc (TILT Holdings Inc., Filed With SEC on September 7, 2023)
Revolving Credit Loan Agreement, dated as of September 5, 2023, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on September 6, 2023)
First Amendment to Amended and Restated Loan and Security Agreement dated July 31, 2023 (4Front Ventures Corp., Filed With SEC on September 1, 2023)
Secured Bridge Loan Agreement, dated August 30, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US Holding, Inc (BioPharmX Corp, Filed With SEC on August 31, 2023)
Loan Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (KEMPHARM, INC, Filed With SEC on August 31, 2023)
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (KEMPHARM, INC, Filed With SEC on August 31, 2023)
First Amendment to the Amended and Restated Loan Agreement between IntelGenx Technologies Corp. and ATAI Life Sciences AG, dated August 31, 2023 (IntelGenx Technologies Corp., Filed With SEC on August 31, 2023)
Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
Omnibus Amendment No. 1 to Fee Letter and Amendment No. 2 to Superpriority Debtor-in-Possession Loan and Security Agreement, dated August 21, 2023, by and between Novan, Inc., EPI... (Novan, Inc., Filed With SEC on August 24, 2023)
Amendment to Forbearance Agreement, dated as of August 15, 2023, among Mallinckrodt plc, Mallinckrodt International Finance S.A., Mallinckrodt CB LLC, certain lenders party... (Mallinckrodt, Filed With SEC on August 15, 2023)
Sixth Amendment to Loan and Security Agreement dated as of May 17, 2023, by and among Alimera Sciences, Inc., SLR Investment Corp., as Collateral Agent, and the parties signatory... (ALIMERA SCIENCES INC, Filed With SEC on August 11, 2023)
Fifth Amendment to Loan and Security Agreement, dated as of May 16, 2023, by and among East West Bank, Journey Medical Corporation and JG Pharma, Inc (Journey Medical Corp, Filed With SEC on August 10, 2023)
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement dated as of August 9, 2023, among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc., the... (ORAMED PHARMACEUTICALS INC., Filed With SEC on August 9, 2023)
Amendment No.1 to Revolving Credit and Term Loan Agreement, dated as of April 20, 2023, by and among Rondo Holdings, LLC, Rondo Intermediate Holdings, LLC, the Subsidiary Loan... (Amneal Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
Amendment No. 1 to Term Loan Credit Agreement, dated as of May 30, 2023, entered into by and among Amneal Pharmaceuticals LLC, the Guarantors, and JPMorgan Chase Bank, N.A. as... (Amneal Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)